ROBIN MYERS: Open Payments
NPI 1659492973 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 12 payments from 8 companies in 2025. Trend: 2023 $178 · 2024 $231 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Myriad Genetic Laboratories, Inc. | 2 | $38 |
| W. L. Gore & Associates, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $28 |
| Boston Scientific Corporation | 1 | $23 |
| CONMED Corporation | 1 | $16 |
Products named: LYNPARZA, JEMPERLI, MYRISK, GORE ENFORM Preperitoneal Biomaterial, ELAHERE, SpyGlass Discover, KEYTRUDA, CONMED SPECIMEN RETRIEVAL.
Industry payments across GA — which companies pay providers there.
